{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:53:34Z","timestamp":1793159614291,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.jneuroim.2006.08.001","type":"journal-article","created":{"date-parts":[[2006,9,30]],"date-time":"2006-09-30T07:24:00Z","timestamp":1159601040000},"page":"57-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids"],"prefix":"10.1016","volume":"181","author":[{"given":"Michelle","family":"Roche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2006.08.001_bib1","first-page":"3","article-title":"Endotoxin and the hypothalamo\u2013pituitary\u2013adrenal (HPA) axis","volume":"9","author":"Beishuizen","year":"2003","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib2","doi-asserted-by":"crossref","first-page":"9317","DOI":"10.1073\/pnas.97.16.9317","article-title":"Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation","volume":"97","author":"Bethin","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000080145","article-title":"Vasoactive intestinal peptide can modulate immune and endocrine responses during lipopolysaccharide-induced acute inflammation","volume":"11","author":"Bik","year":"2004","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1432-1033.1993.tb17910.x","article-title":"Cannabinoid-receptor expression in human leukocytes","volume":"214","author":"Bouaboula","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nbd.2005.03.002","article-title":"Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and\/or vanilloid receptors in a rat model of multiple sclerosis","volume":"20","author":"Cabranes","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/jcb.1103","article-title":"Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids","volume":"81","author":"Chang","year":"2001","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s002130000481","article-title":"Cannabinoid receptors and reward in the rat: a conditioned place preference study","volume":"151","author":"Cheer","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pain.2005.03.043","article-title":"Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve","volume":"116","author":"Costa","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib10","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.neuroscience.2006.02.074","article-title":"Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain","volume":"139","author":"Cristino","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bjp.0705412","article-title":"Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents","volume":"140","author":"Croci","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1432-1327.1999.00631.x","article-title":"Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages","volume":"264","author":"Di Marzo","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"The endocannabinoid system and its therapeutic exploitation","volume":"3","author":"Di Marzo","year":"2004","journal-title":"Nat. Rev., Drug Discov."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/glia.10177","article-title":"Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide","volume":"41","author":"Facchinetti","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1570159043476918","article-title":"Cannabinoids as analgesic agents: evidence from in vivo studies","volume":"2","author":"Finn","year":"2004","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.0953-816X.2004.03177.x","article-title":"Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain","volume":"19","author":"Finn","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Galiegue","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0022-3565(24)37086-7","article-title":"Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid","volume":"283","author":"Gallily","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1567-5769(01)00200-4","article-title":"Effect of the cannabinoid receptor ligand, WIN 55,212-2, on superoxide anion and TNF-alpha production by human mononuclear cells","volume":"2","author":"Germain","year":"2002","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/156800705774322111","article-title":"Cannabinoids","volume":"4","author":"Grotenhermen","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib21","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2005.03.002","article-title":"Cannabinoids and neuroprotection in CNS inflammatory disease","volume":"233","author":"Jackson","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib23","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1124\/jpet.103.051961","article-title":"Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes","volume":"306","author":"Kaplan","year":"2003","journal-title":"J. Pharmacol. Exp Ther."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bjp.0705304","article-title":"Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor","volume":"139","author":"Klegeris","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","article-title":"Cannabinoid-based drugs as anti-inflammatory therapeutics","volume":"5","author":"Klein","year":"2005","journal-title":"Nat. Rev., Immunol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/15287399109531496","article-title":"Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo","volume":"32","author":"Klein","year":"1991","journal-title":"J. Toxicol. Environ. Health"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib27","first-page":"R1870","article-title":"Role of circulating endotoxin and interleukin-6 in the ACTH and corticosterone response to intraperitoneal LPS","volume":"273","author":"Lenczowski","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/abbi.2001.2500","article-title":"Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes","volume":"393","author":"Maccarrone","year":"2001","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1568010023344878","article-title":"Endocannabinoid degradation, endotoxic shock and inflammation","volume":"1","author":"Maccarrone","year":"2002","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-2999(97)01560-4","article-title":"Characterization of the acute endocrine actions of (\u2212)-11-hydroxy-delta8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats","volume":"344","author":"Martin-Calderon","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-2999(96)00015-5","article-title":"N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation","volume":"300","author":"Mazzari","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib33","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0024-3205(98)00140-4","article-title":"A local immuno-endocrine interaction may mediate rat adrenal glucocorticoid response to bacterial endotoxins","volume":"62","author":"Mazzocchi","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/jpet.102.033506","article-title":"Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo","volume":"302","author":"McKallip","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1054\/plef.2001.0340","article-title":"Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression","volume":"66","author":"Mechoulam","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00649-9","article-title":"Endocannabinoids","volume":"359","author":"Mechoulam","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1471-4914(02)02276-1","article-title":"Cannabinoids and brain injury: therapeutic implications","volume":"8","author":"Mechoulam","year":"2002","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib38","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1471-4159.2004.02979.x","article-title":"Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis","volume":"92","author":"Mestre","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0014-5793(98)00851-5","article-title":"The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway","volume":"433","author":"Molina-Holgado","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib40","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1523\/JNEUROSCI.23-16-06470.2003","article-title":"Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia","volume":"23","author":"Molina-Holgado","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib42","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1096\/fj.04-2464fje","article-title":"Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis","volume":"19","author":"Ortega-Gutierrez","year":"2005","journal-title":"Faseb J."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/glia.20229","article-title":"Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures","volume":"52","author":"Ortega-Gutierrez","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib45","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/35097089","article-title":"An endogenous cannabinoid (2-AG) is neuroprotective after brain injury","volume":"413","author":"Panikashvili","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nbd.2005.11.004","article-title":"The endocannabinoid 2-AG protects the blood\u2013brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines","volume":"22","author":"Panikashvili","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1098-1136(20000101)29:1<58::AID-GLIA6>3.0.CO;2-W","article-title":"Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells","volume":"29","author":"Puffenbarger","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib47","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1210\/endo-125-6-2800","article-title":"In the mouse, the activation of the hypothalamic\u2013pituitary\u2013adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1","volume":"125","author":"Rivier","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib48","first-page":"A37","article-title":"The effects of acute lipopolysaccaride injection on levels of pro- and anti-inflammatory cytokines in discrete rat brain regions","volume":"19","author":"Roche","year":"2005","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jneuroim.2006.08.001_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1124\/mol.105.019117","article-title":"Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator activated receptor{gamma} independently of cannabinoid receptors 1 and 2","volume":"70","author":"Rockwell","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-3565(25)12276-3","article-title":"Corticotropin-releasing factor (CRF) antagonist [d-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive\u2013withdrawal behavior in rats","volume":"276","author":"Rodriguez de Fonseca","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0009-3084(02)00159-7","article-title":"Effects of delta-9-tetrahydrocannabinol on human immune function and host defense","volume":"121","author":"Roth","year":"2002","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(00)00307-6","article-title":"In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors","volume":"109","author":"Sacerdote","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0165-5728(94)90152-X","article-title":"Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis","volume":"55","author":"Schwarz","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib54","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)39213-4","article-title":"Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice","volume":"293","author":"Smith","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib55","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(01)01477-7","article-title":"The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models","volume":"432","author":"Smith","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-2999(01)01142-6","article-title":"Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands","volume":"425","author":"Smith","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib57","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1523\/JNEUROSCI.10-11-03701.1990","article-title":"Brain IL-1-induced immunosuppression occurs through activation of both pituitary\u2013adrenal axis and sympathetic nervous system by corticotropin-releasing factor","volume":"10","author":"Sundar","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib58","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0361-9230(01)00445-2","article-title":"Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide","volume":"54","author":"Turrin","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib59","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0022-3565(24)38093-0","article-title":"The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells","volume":"288","author":"Waksman","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib61","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bjp.0705667","article-title":"Cannabinoids and neuroinflammation","volume":"141","author":"Walter","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib60","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003","article-title":"Nonpsychotropic cannabinoid receptors regulate microglial cell migration","volume":"23","author":"Walter","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib62","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0024-3205(95)02047-M","article-title":"Cytokine-to-brain communication: a review and analysis of alternative mechanisms","volume":"57","author":"Watkins","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib63","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000126646","article-title":"Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo\u2013pituitary\u2013adrenal axis in the rat","volume":"59","author":"Weidenfeld","year":"1994","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jneuroim.2006.08.001_bib64","first-page":"E825","article-title":"Differential effects of corticosteroids on rat peripheral blood T-lymphocyte mitogenesis in vivo and in vitro","volume":"265","author":"Wiegers","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jneuroim.2006.08.001_bib65","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572806003110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572806003110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:04:58Z","timestamp":1759046698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572806003110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":65,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0165572806003110"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2006.08.001","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2006.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}